Reduction of Brain β-Amyloid (Aβ) by Fluvastatin, a Hydroxymethylglutaryl-CoA Reductase Inhibitor, through Increase in Degradation of Amyloid Precursor Protein C-terminal Fragments (APP-CTFs) and Aβ Clearance-Reference-Cited by-同舟云学术

Reduction of Brain β-Amyloid (Aβ) by Fluvastatin, a Hydroxymethylglutaryl-CoA Reductase Inhibitor, through Increase in Degradation of Amyloid Precursor Protein C-terminal Fragments (APP-CTFs) and Aβ Clearance

Published:2010-07 Issue:29 Volume:285 Page:22091-22102
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Shinohara Mitsuru,Sato Naoyuki,Kurinami Hitomi,Takeuchi Daisuke,Takeda Shuko,Shimamura Munehisa,Yamashita Toshihide,Uchiyama Yasuo,Rakugi Hiromi,Morishita Ryuichi

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference62 articles.

1. Alzheimer's centennial legacy: prospects for rational therapeutic intervention targeting the A amyloid pathway

2. Chronic Treatment with the γ-Secretase Inhibitor LY-411,575 Inhibits β-Amyloid Peptide Production and Alters Lymphopoiesis and Intestinal Cell Differentiation

3. Consequence of Aβ immunization on the vasculature of human Alzheimer's disease brain

4. Alzheimer's disease: on the verges of treatment and prevention

5. Long-term effects of Aβ42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low-Density Lipoprotein Receptor-Related Protein 1 as a Potential Therapeutic Target in Alzheimer’s Disease;Pharmaceutics;2024-07-17

2. Targeting dysregulated lipid metabolism for the treatment of Alzheimer's disease and Parkinson's disease: Current advancements and future prospects;Neurobiology of Disease;2024-06

3. Glymphatic pathway: An emerging perspective in the pathophysiology of neurodegenerative diseases;International Journal of Geriatric Psychiatry;2024-06

4. Lipid rafts disruption by statins negatively impacts the interaction between SARS-CoV-2 S1 subunit and ACE2 in intestinal epithelial cells;Frontiers in Microbiology;2024-01-08

5. Reconsidering the role of blood-brain barrier in Alzheimer’s disease: From delivery to target;Frontiers in Aging Neuroscience;2023-02-16